5 hours Krystal Q3 Earnings and Sales Top Estimates, Vyjuvek Gains TractionZacks
KRYS beat on both earnings and sales in the third quarter of 2024. Lead drug Vyjuvek’s launch in the United States shows strong uptake.
X NYSE Nasdaq 100 Earnings Tech Science SEC U.S. Politics AI Business Energy Dow Jones Wall Street Dividend Investing Markets Crude Oil China Economy Wealth S&P 500 World Real Estate Bitcoin (BTC) NVIDIA (NVDA) Health Software Tesla (TSLA) 3M (MMM) Fed Insurance Gold Natural Gas Money Inflation Canada Entertainment Apple (AAPL) U.K. Options Pharmaceuticals Boeing (BA) Amazon (AMZN) Construction Retail Security Meta Platforms (META) Europe Microsoft (MSFT) Current JPMorgan (JPM) Hedge Funds Retirement Mining Jim Cramer Manufacturing Taxes Google Wells Fargo&Co (WFC) Goldman Sachs (GS) Truist Financial Corp (TFC) Donald Trump Netflix (NFLX) Finance Sports Aerospace Elon Musk Bank of America (BAC) Morgan Stanley (MS) Tax York New York Cars Enterprise Silver Airlines Live Japan REITs Israel Internet Economics Interest Rates Kamala Harris Costco (COST) Space Milton Mortgage Property IPOs Texas Boston Florida Warren Buffett Intel (INTC) Compound (COMP) BlackRock (BLK) ASML (ASML) AMD (AMD) WarMore +
